Table 1 Characteristics of patients treated with rHuEpo and historical controls

From: rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study

  Patients   Controls   P-value
MM (number of tandem transplant) 7 (4)   10 (5)   
MCL 1   3   
Lymphoma in relapse 3   4   
  Mean (s.d.) Mean (s.d.)  
Age (range) 57 (9.5) (33–66) 53 (7.7) (34–69) 0.25
Number of CD34 ( × 106/kg) (s.d.) 4 (1.8) 4.8 (3.6) 0.4
Day of hospitalization 22.6 (3.3) 25.6 (4.1) 0.02
Number of platelet transfusion 2.2 (2.4) 2.9 (2.4) 0.38
Hb level at diagnosis (g/dl) 10.3 (2.3) 11.6 (1.5) 0.17